racy is general partner of Astarte Ventures, an early stage investment firm focused exclusively on women’s and children’s health and wellbeing. The firm has made investments in eight companies with technologies focused on women and children, including Maven, Prima-Temp, Naya Health and Madorra. Through Astarte Ventures, Tracy and her co-founders came together to form Astarte Medical to dramatically impact the lives of preterm infants. As founding CEO, she leverages her experience of serial entrepreneurship and over 15 years as a venture capitalist and early stage investor to lead strategy and fundraising.
Prior to Astarte Ventures, Tracy served as general partner at Battelle Ventures and focused on investments in health & life sciences, as well as emerging energy technologies, with an emphasis on institutional-based transactions. She led investments based on technologies licensed from national laboratories and leading universities, including Princeton University, California Institute of Technology, University of Pennsylvania and Oak Ridge National Laboratory. Tracy led the firm’s investments in NuPathe (PATH; acquired by Teva Pharmaceuticals in 2014 for $140 million), BioNano Genomics, Micro Interventional Devices and SmartSynch (sold to Itron for $100 million).
Tracy has been working with institutions to commercialize groundbreaking science since 2003. During that time she has worked closely with the technology transfer and economic development organizations in medical centers, universities and laboratories, including six of the U.S. Department of Energy National Laboratories, and the Health and Life Sciences division of Battelle Memorial Institute, which is the world's largest nonprofit research and development organization. This experience led Tracy to found FedIMPACT, LLC in 2014, a commercialization enterprise to identify and launch technologies from federal laboratories. Having successfully spun-out four companies in just 18 months with over $5M of funding, FedIMPACT was acquired by IP Group, plc in December 2016.
In 2007, while at Battelle Ventures, Tracy co-founded NellOne Therapeutics, a biotechnology company focused on soft tissue regeneration, initially in veterinary but ultimately for human applications.
Leveraging her vast experience in commercializing technologies from the nation’s leading institutions, Tracy serves on the Board of Children’s Research Institute (CRI) at Children’s National Medical Center (Washington, DC) and formerly served on the Board of Clemson University Research Foundation, and is a member of the Business Advisory Council to the Sheikh Zayed Institute for Pediatric Surgical Innovation. In addition to her investment activities, she also provides early-stage leadership to other businesses, currently serving as an adviser and mentor to life science female entrepreneurs through Springboard Enterprises and co-chairs the Portfolia Active Aging Fund.
Tracy received her BS in Accounting and International Business from New York University and her MBA at Columbia Business School in Finance.